The U.S. Consumer Product Safety Commission (CPSC) announced that the Powell Company is recalling its Anywhere Lounger bean bag chairs due to a safety hazard for children.

The CPSC issued a release that reads: “Bean bag chairs without a permanent zipper closure allow young children to unzip, ingest or inhale the small beads inside of the bean bag chair, posing a suffocation and strangulation hazard.”

More CPSC Recalls Bean Bag Chairs that Pose a Safety Hazard to Children

The debate over whether cellphone usage can lead to an increased risk of cancer has been going on for years, with scientists and researchers chiming in on both sides. However, in recent years, more and more experts and organizations have begun to accept the fact that cellular devices may actually pose a danger to one’s health.

Recently, the World Health Organization re-classified cellphone radiation as a “possible carcinogen similar to car exhaust,” Cbs58.com reported. ?The organization cited a study that looked at 10 years of research and dozens of people, which concluded that cellphone radiation can lead to brain tumors. Then this spring, the Federal Communications Commission (FCC) announced that it is reviewing additional outside studies to decide if it should alter the current limits it set regarding how much radiation cellphones are allowed to emit, Cbs58.com reported.

More Possible Link Between Cancer and Cellphones Gets Another Look

A Dayton, Ohio, woman was indicted by a Montgomery County grand jury on Monday on felony charges of patient abuse.

Norma Black, 70, was an employee at the Arbors at Dayton Subacute and Rehabilitation Center when she abused a patient by smacking him, a fourth-degree felony. Black was issued a summons to appear in court, and she is scheduled to be arraigned on May 28. The abuse allegedly occurred during March 2012. Black was an activity assistant at the facility from 2007 until March 23, 2012, according to whiotv.com. More Ohio Woman Indicted on Nursing Home Abuse Charges

A lawsuit has been filed on behalf of a Mississippi woman who alleges she was injured after being implanted with two transvaginal mesh devices. The suit was filed on April 30 in the U.S. District Court for the Southern District of West Virginia, Charleston Division, where it has joined dozens of other pending cases in a multidistrict litigation (MDL). Ethicon Inc., Ethicon LLC and Johnson & Johnson have been named as defendants.

The Plaintiff, who is represented by the national law firm Parker Waichman LLP, is suing for negligence on three counts of strict liability (design defect, manufacturing defect and failure to warn), breach of express and implied warranty, fraudulent concealment and punitive damages. She alleges that she was implanted with the Prolift and TVT sling on November 20, 2008. According to the complaint, the device is defective and caused a number of injuries. The Defendant is accused of knowing about the risks associated with the mesh products but failing to warn the Plaintiff, her doctor, or consumers. More Lawsuit Filed on Behalf of Mississippi Woman Allegedly Injured by Transvaginal Mesh Devices

The quarterly sales are in for Merck & Co Inc.’s diabetes medicine Januvia, and they are not good.

Januvia, Merck’s s biggest product, fell 4 percent to $884 million. The drop in earnings led Merck to cut its full-year profit forecast on Wednesday, Reuters reported. Overall, shares of Merck fell 1.6 percent to $46.23. It is believed that the drop is due to concern from investors about slower growth for Januvia and whether Merck could bring promising new drugs to market in the near future.

More Concern over Diabetes Drug Januvia Pulls Down Merck’s Quarterly Sales

Ranbaxy settled an eight-year dispute with the U.S. Food and Drug Administration (FDA) yesterday at the cost of $500 million.

Former director and global head of Research Information and Portfolio Management at Ranbaxy Laboratories, Dinesh Thakur, will go down in history as the man who brought down the Indian company in the United States’ most high-profile generic drug violation case in history. With the whistleblower’s help, the government was able to unravel years of falsified records and dangerous manufacturing practices within Ranbaxy, drawing attention to the need for better regulation of drugs sold in the U.S., regardless of where they are made. Thakur will receive $48.5 million for his efforts, according to Moneycontrol.com. More Ranbaxy Settles with FDA for $500 Million; Whistleblower to Get $48.5 Million

An Ohio widow of a man who allegedly developed bladder cancer and subsequently died from using Actos has filed a lawsuit against Takeda Pharmaceutical.

According to the lawsuit, the man took Actos from June 2002 to February 2007, at about which time he stopped taking the drug and had developed bladder cancer. He passed away in September 2007 of the bladder cancer, which the lawsuit claims was caused by Actos. The suit accuses Takeda of knowing that taking Actos could lead to an increased risk of bladder cancer and failing to disclose this information to the man, his doctor and other consumers. The suit seeks damages for extensive pain and suffering, and severe emotional distress. Actos’s side effects greatly reduced the decedent’s ability to enjoy life, the suit alleges.

More Ohio Widow Files Actos-Related Lawsuit Against Takeda

A woman has filed a lawsuit alleging that her use of Bayer’s Mirena IUD birth control device cause her to suffer from serious injuries.

According to the lawsuit, the woman was implanted with the Mirena IUD in October 2009. In April 2010, she went to her doctor’s office complaining of pain. Her physician was unable to see the strings, and could not find the IUD using ultrasound. An x-ray revealed that her Mirena IUD was within the abdominal cavity located outside the uterus. As a result, the woman had to undergo laparoscopic surgery to remove the Mirena IUD in May 2010.

More Woman Sues over Mirena IUD, Claims it Moved to Abdominal Cavity

A federal judge approved on Monday a $40 million class action settlement between Skechers USA Inc. and consumers who purchased its toning shoes.

The settlement was made after lawsuits poured in claiming that Sketcher advertisements were making unfounded statements that the company’s footwear would help people lose weight and strengthen muscles, ABC News said. U.S. District Judge Thomas B. Russell approved the deal, which covers more than 520,000 lawsuits.

More Federal Judge Approves $40 Million Class Action Settlement for Skechers

A $2.2 billion settlement of a federal investigation into Johnson & Johnson (J&J) sales practices has been placed on hold, as the company attempts to avoid wording in the agreement that could leave it susceptible to additional lawsuits.

Last year, J&J agreed to pay $2.2 billion to settle a Justice Department investigation into allegations that the health ­products company had illegally promoted drugs, including the anti-psychotic Risperdal, The Wall Street Journal reported.

More $2.2 Billion Settlement on Hold as J&J Seeks to Hault Further Probes